Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20.8M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
13M
-
Shares change
-
-478K
-
Total reported value, excl. options
-
$32.5M
-
Value change
-
-$1.44M
-
Number of buys
-
25
-
Number of sells
-
-37
-
Price
-
$2.50
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q2 2017
78 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q2 2017.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13M shares
of 20.8M outstanding shares and own 62.48% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (2M shares), FMR LLC (1.81M shares), RENAISSANCE TECHNOLOGIES LLC (1.42M shares), EcoR1 Capital, LLC (874K shares), MILLENNIUM MANAGEMENT LLC (590K shares), Numeric Investors LLC (559K shares), VANGUARD GROUP INC (548K shares), PRIMECAP MANAGEMENT CO/CA/ (491K shares), 683 Capital Management, LLC (425K shares), and BlackRock Inc. (338K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.